Biognosys launches groundbreaking P2 Plasma Enrichment technology for unbiased, deep plasma proteomics at ASMS 2024
May 30, 2024 09:15 ET
|
Biognosys AG
Biognosys launches single-well, single particle-type P2 Plasma Enrichment technology with market-leading performance for unbiased, deep plasma proteomics
Global Multiomics Market Forecast at $11.61 Billion by 2034: Rising Cancer Incidence and Demand for Personalized Therapies Fuel Adoption of Multiomic Approaches in Oncology
May 29, 2024 07:43 ET
|
Research and Markets
Dublin, May 29, 2024 (GLOBE NEWSWIRE) -- The "Global Multiomics Market" report has been added to ResearchAndMarkets.com's offering.The global multiomics market accounted for USD 2.40 billion in...
IMAC Holdings Announces Leadership Succession
May 24, 2024 09:00 ET
|
IMAC Holdings, Inc.
Faith Zaslavsky appointed as CEO to succeed Jeff Ervin FRANKLIN, Tenn., May 24, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC”) today announced leadership transitions to the...
Single Domain Antibody Platforms MarketResearch 2024-2031: Strategic Collaborations Driving Expansion, Focus on Pioneering Cancer Treatments, US Leads Innovations
May 24, 2024 04:28 ET
|
Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Single Domain Antibody Platforms Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade,...
Ampicillin Market Is Expected To Reach A Revenue Of USD 480.1 Mn By 2033, At 2.4% CAGR: Insights by Dimension Market Research
May 21, 2024 13:49 ET
|
Dimension Market Research
New York, May 21, 2024 (GLOBE NEWSWIRE) -- Overview The Global Ampicillin Market size is expected to reach USD 388.1 million by 2024 and is further anticipated to reach USD 480.1 million by...
Certara Appoints New Chief Human Resources Officer & General Counsel
May 21, 2024 08:00 ET
|
Certara
Certara has appointed Rona Anhalt as Chief Human Resources Officer and Daniel Corcoran as General Counsel.
Novartis highlights pioneering innovation in CML with data from Scemblix® Phase III ASC4FIRST study in newly diagnosed patients at ASCO and EHA
May 15, 2024 10:00 ET
|
Novartis Pharma AG
Primary results of the Scemblix® ASC4FIRST pivotal Phase III study in first-line Ph+ CML-CP supporting third US FDA Breakthrough Therapy designation, to be detailed in the ASCO Press Program and the...
Drug Discovery Informatics Market Worth $8.17 Billion by 2031: Global Industry Analysis Featuring Profiles of Certara, Infosys, Collaborative Drug Discovery, Jubliant Biosys, Curia Global
May 15, 2024 03:41 ET
|
Research and Markets
Dublin, May 15, 2024 (GLOBE NEWSWIRE) -- The "Drug Discovery Informatics Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis by Workflow, Service,...
Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)
May 14, 2024 11:00 ET
|
Organovo, Inc.
Organovo will be presenting data on the Company’s lead clinical-stage drug, FXR314 during DDW2024, which is being held in Washington, D.C. May 18-21, 2024
Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments
May 13, 2024 08:00 ET
|
Barinthus Biotherapeutics
Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments